![]() |
OBJECTIVESNanobiotechnology as one of todays most fascinating and challenging field of research is a multidisciplinary and fast developing research area with revolutionary innovations in almost any field of science and engineering. |
The major focus of the NanoBio-Europe Congress is set on medical applications of nanobio technology, in particular the characterization of cellular processes, machinery and interaction to control, manipulate or manufacture molecules or supramolecular assemblies to improve human health.
| Holger Becker, microfluidic ChipShop GmbH, D Francois Chatelain, Cytoo SA, F Mike Eaton, University of Birmingham, UK Andreas Engel, University of Basel. CH Mauro Ferrari, Univ. of Texas, Health Science Center, US Han Gardeniers, MESA+, University of Twente, NL Randy Goodall, NanoMedical Systems Inc, US |
Antje Grobe, IZKT, University of Stuttgart, D Andreas Jacobs, EIMI,D Jorgen Kjems, iNano, DK Michael H. Kuhn, Philips Healthcare, D Claus-Michael Lehr, Saarland University, D Cristian Strassert, University of Münster, D Marcus Textor, ETH Zürich, CH |
| Topics covered • Nano-enabled drug delivery • Nanotechnology for medical applications • In vivo imaging • Biomarkers and nanoparticles • Cell analysis and manipulation • Sensors and actuators • Bioanalytics • Bio-nano materials and tissues • Ethical, social and regulatory issues |
Applications covered • Diagnostics • Therapeutics • Medical applications • Body monitoring • Environmental monitoring • Drug screening and development |

After five successful congresses in Münster, Grenoble and Barcelona taking place at yearly intervals NanoBio-Europe will once again be hosted in Münster. Europe’s leading congress on nanobiotechnology offers three days of:
• Plenary talks
• Thematic sessions
• Nanobio in North Rhine-Westphalia
• Industrial exhibition
• SMI sessions
• Technical visits
| Alfred Benninghoven, ION-TOF GmbH, D Flemming Besenbacher, iNANO, DK Patrick Boisseau, CEA, F Mike Eaton, University of Birmingham, UK Harald Fuchs, CeNTech, D Paul Galvin, Tyndall University, IRL Furio Gramatica, Don Gnocchi Foundation, I Hans Hofstraat, Philips Research Laboratories, NL Bengt Kasemo, University of Chalmers, S |
Peter-Andreas Löschmann, Wyeth Pharma GmbH, D Josep Samitier, IBEC, E Michael Schäfers, EIMI, D Jürgen Schnekenburger, University of Münster, D Hans R. Schöler, MPI for Molecular Biomedicine, D Vinod Subramaniam, University of Twente, NL Gert von Bally, University of Münster, D Martin Weber, Qiagen GmbH, D Christiane Ziegler, University of Kaiserslautern, D |

Münster: City of Science and Culture Münster is the academic and cultural centre of the region and a fast growing technology location all-in-one. The city has 280,000 citizens and 60,000 students. It accommodates one of Germany’s largest universities and is a member of the „Historic Highlights of Germany“. Münster’s historic city image, its high streets, restaurants and pubs, its museums and theatres makes the city not only interesting for its citizens.
In 2004 Münster received the International Award for Liveable Communities (LivCom) endorsed by the United Nations Environment Program. The City of Münster has defined Nanobiotechnology as one of the key topics in its approach to further strengthen scientific excellence. The shortly to be erected NanoBio-Center, being co-financed by the City, the designated extension of the Center for Nanotechnology (CeNTech) as well as the new European Institute of Molecular Imaging (EIMI) are only some examples for the further development of the science location Münster.
Münster can easily be reached by plane using the International Airport Münster/Osnabrück and the International Airport of Düsseldorf or Frankfurt, respectively. The city is served by the regular IC/ICE high speed train system.